Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group Study.

Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group Study.

Item
http://www.wikidata.org/entity/Q33873518
Pattern of CD14+ follicular dendritic cells and PD1+ T cells independently predicts time to transformation in follicular lymphoma.Follicular lymphoma: still Six characters in search of an author?Revisiting the immune microenvironment of diffuse large B-cell lymphoma using a tissue microarray and immunohistochemistry: robust semi-automated analysis reveals CD3 and FoxP3 as potential predictors of response to R-CHOPFollicular Lymphoma Tregs Have a Distinct Transcription Profile Impacting Their Migration and Retention in the Malignant Lymph Node.Cell of origin of transformed follicular lymphomaPathogenesis of follicular lymphomaA phase 2 trial of extended induction epratuzumab and rituximab for previously untreated follicular lymphoma: CALGB 50701.The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker ConsortiumFCG (FLIPI, Charlson comorbidity index, and histological grade) score is superior to FLIPI in advanced follicular lymphoma.The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era.Assessing the prognostic impact of immune cell infiltrates in follicular lymphoma.Transformed follicular lymphoma.MicroRNA signatures and Foxp3+ cell count correlate with relapse occurrence in follicular lymphoma.
P2860

Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group Study.

Item
http://www.wikidata.org/entity/Q33873518
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Prognostic value of regulatory ...... outhwest Oncology Group Study.
@ast
Prognostic value of regulatory ...... outhwest Oncology Group Study.
@en
type
label
Prognostic value of regulatory ...... outhwest Oncology Group Study.
@ast
Prognostic value of regulatory ...... outhwest Oncology Group Study.
@en
prefLabel
Prognostic value of regulatory ...... outhwest Oncology Group Study.
@ast
Prognostic value of regulatory ...... outhwest Oncology Group Study.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Prognostic value of regulatory ...... Southwest Oncology Group Study
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932